Respiratory syncytial virus-related pneumonia after stem cell transplantation successfully treated with palivizumab and steroid therapy

Giuseppe Luigi Banna, Savina Maria Luciana Aversa, Anna Maria Cattelan, Gino Crivellari, Silvio Monfardini

Research output: Contribution to journalArticlepeer-review

Abstract

A case is reported of a 56-y-old woman with a second relapse of Hodgkin's disease who early developed after autologous stem cell transplantation (ASCT) a severe RSV-related interstitial pneumonia successfully treated with 1-d intravenous palivizumab 8 mg/kg plus low-dose systemic steroid therapy. B-cells suppression with CMV antigenaemia were then observed and required treatment with ganciclovir and liposomal amfotericine B.

Original languageEnglish
Pages (from-to)155-157
Number of pages3
JournalScandinavian Journal of Infectious Diseases
Volume36
Issue number2
DOIs
Publication statusPublished - 2004

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology

Fingerprint Dive into the research topics of 'Respiratory syncytial virus-related pneumonia after stem cell transplantation successfully treated with palivizumab and steroid therapy'. Together they form a unique fingerprint.

Cite this